Design and manufacture of orthopaedic implants
Nate Folkert, CEO
Matt Tharp, CFO
Chairman of the Board
Orchid’s leading offerings span hip, knee, trauma, extremity and spinal implant products, as well as single-use and multi-use complex instruments used in implant related surgical procedures.
As a strategic partner to the leading global medical device OEMs, Orchid offers solutions in product and procedure design and possesses the full range of manufacturing processes required to produce finished, packaged products. The company serves a global customer base from its 12 manufacturing sites in the US, UK, Switzerland and China. Orchid innovates continually to provide differentiated processes yielding unique products, while simplifying its customers’ supply chains, delivering outstanding quality and offering end-to-end solutions benefitting from the broadest implants portfolio in the market.
Nordic Capital aims to support Orchid’s growth strategy and its continued investment in product and manufacturing innovation, uncompromised clinical quality and integrated offerings through the company’s next phase of development.
EUR 250 million
Nordic Capital Fund IX
Holt, Michigan, USA